Oveporexton - Takeda
Alternative Names: TAK-861Latest Information Update: 12 Feb 2026
At a glance
- Originator Takeda
- Class Benzyl compounds; Biphenyl compounds; Fluorinated hydrocarbons; Ketones; Propanols; Pyrrolidines; Sleep disorder therapies; Small molecules; Sulfonamides
- Mechanism of Action Orexin receptor type 2 agonists
-
Orphan Drug Status
Yes - Narcolepsy
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- Preregistration Narcolepsy
- No development reported Idiopathic hypersomnia